PDT Partners, LLC

Position in KROS — Keros Therapeutics, Inc.

CIK 1564702 New York, NY

Position in KROS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$122,033

-$239,460 QoQ

Shares Held

11,405

-65.2% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#82

of 132 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PDT Partners, LLC holds $58,476,347 across 23 Biotechnology names. KROS ranks #23 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	122,041	$14,287,339
2	RCUS	Arcus Biosciences, Inc.	323,567	$9,975,570
3	FTRE	Fortrea Holdings Inc.	301,272	$5,242,132
4	AUPH	Aurinia Pharmaceuticals Inc.	265,491	$4,505,382
5	ARQT	Arcutis Biotherapeutics, Inc.	155,075	$4,066,066
6	ROIV	Roivant Sciences Ltd.	108,100	$3,825,659
7	CLDX	Celldex Therapeutics, Inc.	80,899	$3,010,251
8	TGTX	Tg Therapeutics, Inc.	41,585	$2,284,679

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$122,033	11,405	-65.2%	Shares	Sole	2026-08-14
2026-03-31	$361,493	32,744	-70.8%	Shares	Sole	2026-05-15
2025-12-31	$2,284,045	112,183	-66.3%	Shares	Sole	2026-02-17
2025-09-30	$5,265,133	332,815	0.0%	Shares	Sole	2025-11-17
2025-06-30	$4,443,080	332,815	+20.6%	Shares	Sole	2025-08-14
2025-03-31	$2,813,051	276,060	+1118.4%	Shares	Sole	2025-05-15
2023-03-31	$967,453	22,657	+0.2%	Shares	Sole	2023-05-15
2022-12-31	$1,085,300	22,601	-0.3%	Shares	Sole	2023-02-14
2022-09-30	$852,582	22,663	-52.3%	Shares	Sole	2022-11-14
2022-06-30	$1,313,695	47,546	+177.2%	Shares	Sole	2022-08-15
2022-03-31	$932,888	17,155	+342.6%	Shares	Sole	2022-05-16
2021-03-31	$238,567	3,876	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.